Santiago Montes-Moreno

Summary

Country: Spain

Publications

  1. doi request reprint SPIB, a novel immunohistochemical marker for human blastic plasmacytoid dendritic cell neoplasms: characterization of its expression in major hematolymphoid neoplasms
    Santiago Montes-Moreno
    Pathology Department, Hospital Universitario Marques de Valdecilla, Instituto de Formación e Investigación Marqués de Valdecilla, Santander, Spain
    Blood 121:643-7. 2013
  2. doi request reprint EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation
    Santiago Montes-Moreno
    Pathology Department, Hospital Universitario Marques de Valdecilla, IFIMAV, Santander, Spain
    Mod Pathol 25:968-82. 2012
  3. doi request reprint Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge
    Santiago Montes-Moreno
    Oncology Department, Hospital Ramon y Cajal, Madrid, Spain
    Leuk Lymphoma 53:185-94. 2012
  4. ncbi request reprint Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas
    Santiago Montes-Moreno
    Lymphoma Group, Spanish National Cancer Centre CNIO, Madrid, Spain
    Blood 111:351-8. 2008
  5. pmc Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype
    Santiago Montes-Moreno
    Lymphoma Group, Molecular Pathology Programme Spanish National Cancer Research Centre, CNIO, Madrid, Spain
    Haematologica 95:1342-9. 2010
  6. pmc Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features
    George Kanellis
    Spanish National Cancer Research Centre CNIO, Madrid, Spain
    Haematologica 95:1122-9. 2010
  7. doi request reprint miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy
    Santiago Montes-Moreno
    Lymphoma Group, Spanish National Cancer Research Centre CNIO, Madrid, Spain
    Blood 118:1034-40. 2011
  8. ncbi request reprint PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma
    Jose Francisco Garcia
    Monoclonal Antibodies Unit, Biotechnology Program, Spanish National Cancer Centre CNIO, Madrid, Spain
    Haematologica 91:467-74. 2006
  9. doi request reprint Peripheral T-cell lymphoma with follicular T-cell markers
    Socorro Maria Rodriguez-Pinilla
    Lymphoma Group, Molecular Pathology Programme, Spanish National Cancer Research Centre CNIO, Madrid, Spain
    Am J Surg Pathol 32:1787-99. 2008
  10. doi request reprint PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma
    Syong H Nam-Cha
    Lymphoma Group, Molecular Pathology Programme, Spanish National Cancer Centre CNIO, Madrid, Spain
    Am J Surg Pathol 32:1252-7. 2008

Collaborators

  • Lorena Maestre
  • Francisca I Camacho
  • Juan F Garcia
  • Jose Rodriguez
  • Izaskun Trébol
  • Luis Requena
  • Lorenzo Cerroni
  • Adonina Tardon
  • Nuria Malats
  • Josep Lloreta
  • Francisco X Real
  • Alfredo Carrato
  • Jose Luis Rodriguez-Peralto
  • Syong H Nam-Cha
  • Elias Campo
  • Marcos Malumbres
  • Eva Kimby
  • Yulei Shen
  • Teresa Marafioti
  • Renato Franco
  • Estella Matutes
  • Cherie Dunphy
  • Miguel A Piris
  • Socorro Maria Rodriguez-Pinilla
  • Socorro M Rodriguez-Pinilla
  • Miguel Angel Piris
  • Manuela Mollejo
  • Veronica Monsálvez
  • Pablo L Ortiz-Romero
  • Lorena Di Lisio
  • Lydia Sanchez
  • Raquel Pajares
  • Margarita Sanchez-Beato
  • Nerea Martinez
  • Giovanna Roncador
  • Lina Odqvist
  • Azahara Martínez-López
  • Maciej J Czachorowski
  • Teresa Flores
  • María J Bueno
  • Rocio Ramos-Medina
  • Carlos Barrionuevo
  • Sandro Casavilca
  • Jaime Montes
  • David G Pisano
  • George Kanellis
  • Juan C Cigudosa
  • Socorro Maria Rodriguez Pinilla
  • Mohit Aggarwal
  • Francisco J Martinez-Tello
  • Maria E Rodriguez
  • Maria Lozano
  • Gloria Camacho
  • Juan Carlos Solera-Arroyo
  • Javier Menarguez Palanca
  • Manuel Almagro
  • Esperanza Martin-Sanchez
  • Cesar Miranda-Vallina
  • Juan Luis Alfonso Martin
  • Carlos Gonzalez
  • Agueda Pulpillo
  • Federico García Bragado
  • Itziar Eraña Tomás
  • Jose Miguel Bosch
  • Valeria Peri
  • Francisco Mazorra
  • Yolanda Castro
  • Purificación Domínguez Franjo
  • Rafael Ramos-Asensio
  • Begoña Echevarría
  • Carlos Ulibarrena
  • Lidia Sanchez-Verde
  • Maria J Artiga
  • Montse Fernandez-Alvarez
  • Beatriz S Espiridión
  • Ricardo Fernandez-de-Misa
  • Amparo Sevilla
  • Julio Alexander Díaz-Pérez
  • Ana Burdaspal
  • Beatriz Sánchez-Espiridión
  • Alberto Puime Otín
  • Francisca Iniesta-Martínez
  • Maria Isabel Longo
  • Lydia Sanchez-Verde
  • Manolis Kogevinas
  • André F S Amaral
  • Miguel Piris-Villaespesa
  • Manuel M Morente
  • Adriana Lázaro
  • Marta Gómez de Cedrón

Detail Information

Publications25

  1. doi request reprint SPIB, a novel immunohistochemical marker for human blastic plasmacytoid dendritic cell neoplasms: characterization of its expression in major hematolymphoid neoplasms
    Santiago Montes-Moreno
    Pathology Department, Hospital Universitario Marques de Valdecilla, Instituto de Formación e Investigación Marqués de Valdecilla, Santander, Spain
    Blood 121:643-7. 2013
    ..We conclude that SPIB expression can be used as a tool for diagnosing BPDC neoplasms, but it needs to be tested in conjunction with the growing arsenal of markers for human plasmacytoid dendritic cells...
  2. doi request reprint EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation
    Santiago Montes-Moreno
    Pathology Department, Hospital Universitario Marques de Valdecilla, IFIMAV, Santander, Spain
    Mod Pathol 25:968-82. 2012
    ..Thus, alternative therapies, based on the tumor biology, need to be tested in patients with EBV-positive diffuse large B-cell lymphoma of the elderly...
  3. doi request reprint Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge
    Santiago Montes-Moreno
    Oncology Department, Hospital Ramon y Cajal, Madrid, Spain
    Leuk Lymphoma 53:185-94. 2012
    ....
  4. ncbi request reprint Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas
    Santiago Montes-Moreno
    Lymphoma Group, Spanish National Cancer Centre CNIO, Madrid, Spain
    Blood 111:351-8. 2008
    ..The results of RNA and protein expression should prompt further investigation into the role of Gcet1 in regulating B-cell survival...
  5. pmc Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype
    Santiago Montes-Moreno
    Lymphoma Group, Molecular Pathology Programme Spanish National Cancer Research Centre, CNIO, Madrid, Spain
    Haematologica 95:1342-9. 2010
    ..Plasmablastic lymphoma has recently come to be considered a distinct entity among mature B cell neoplasms, although the limits with diffuse large B-cell lymphoma (DLBCL) need to be more accurately defined...
  6. pmc Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features
    George Kanellis
    Spanish National Cancer Research Centre CNIO, Madrid, Spain
    Haematologica 95:1122-9. 2010
    ..Additional work is required to review this entity and establish its diagnostic features...
  7. doi request reprint miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy
    Santiago Montes-Moreno
    Lymphoma Group, Spanish National Cancer Research Centre CNIO, Madrid, Spain
    Blood 118:1034-40. 2011
    ..This information improves upon IPI-based predictions and identifies a subgroup of candidate patients for alternative therapeutic regimens...
  8. ncbi request reprint PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma
    Jose Francisco Garcia
    Monoclonal Antibodies Unit, Biotechnology Program, Spanish National Cancer Centre CNIO, Madrid, Spain
    Haematologica 91:467-74. 2006
    ..The positive regulatory domain I (PRDM1) protein or BLIMP-1, belonging to the PRDM gene family of transcriptional repressors, is a key regulator of terminal differentiation in B-lymphocytes and is critical for plasma cell differentiation...
  9. doi request reprint Peripheral T-cell lymphoma with follicular T-cell markers
    Socorro Maria Rodriguez-Pinilla
    Lymphoma Group, Molecular Pathology Programme, Spanish National Cancer Research Centre CNIO, Madrid, Spain
    Am J Surg Pathol 32:1787-99. 2008
    ..The aim of this study was to establish whether other PTCL subgroups also express TFH cell markers...
  10. doi request reprint PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma
    Syong H Nam-Cha
    Lymphoma Group, Molecular Pathology Programme, Spanish National Cancer Centre CNIO, Madrid, Spain
    Am J Surg Pathol 32:1252-7. 2008
    ..The standard T/HRBCL cases lack follicular T-cell rosettes, whereas most of the borderline cases between the 2 entities have follicular T-cell rosettes, thus suggesting a closer relation with NLPHL...
  11. doi request reprint The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas
    Lorena Di Lisio
    Hospital Universitario Marqués de Valdecilla HUMV Instituto de Formación e Investigación Marqués de Valdecilla IFIMAV, Santander, Spain
    Blood 120:1782-90. 2012
    ..They identify miRNAs that could be used for diagnosis, prognosis, or prediction of response to specific therapies...
  12. doi request reprint Epstein-Barr virus-positive systemic NK/T-cell lymphomas in children: report of six cases
    Socorro M Rodriguez-Pinilla
    Lymphoma Group, Molecular Pathology Programme, Spanish National Cancer Research Centre CNIO, Madrid, Spain
    Histopathology 59:1183-93. 2011
    ..The aim of this study was to characterize six cases of paediatric EBV-positive peripheral T-cell lymphoma with distinct features...
  13. doi request reprint NIK controls classical and alternative NF-κB activation and is necessary for the survival of human T-cell lymphoma cells
    Lina Odqvist
    Molecular Pathology Programme, Spanish National Cancer Research Centre CNIO, Madrid, Spain
    Clin Cancer Res 19:2319-30. 2013
    ..We investigated the function of the NF-κB-inducing kinase (NIK), in this pathway and its role as a potential molecular target in T-cell lymphomas...
  14. doi request reprint Immunohistochemical analysis of HLDA9 Workshop antibodies against cell-surface molecules in reactive and neoplastic lymphoid tissues
    Rocio Ramos-Medina
    Monoclonal Antibodies Unit, Biotechnology Programme, Spanish National Cancer Research Centre, Madrid, Spain
    Immunol Lett 134:150-6. 2011
    ....
  15. doi request reprint EBV-associated cutaneous NK/T-cell lymphoma: review of a series of 14 cases from peru in children and young adults
    Socorro Maria Rodriguez-Pinilla
    Lymphoma Group, Molecular Pathology Programme, Spanish National Cancer Research Centre, CNIO, Madrid, Spain
    Am J Surg Pathol 34:1773-82. 2010
    ....
  16. doi request reprint MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma
    Veronica Monsálvez
    Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain
    Mod Pathol 26:171-81. 2013
    ..05). In summary, miRNA expression analysis can be used as a tool for diagnosis and outcome prognosis in indolent primary cutaneous B-cell lymphoma...
  17. doi request reprint TCR-γ expression in primary cutaneous T-cell lymphomas
    Socorro Maria Rodriguez-Pinilla
    CNIO Lymphoma Group, Fundacion Jimenez Diaz, Madrid, Spain
    Am J Surg Pathol 37:375-84. 2013
    ..Moreover, its expression does not seem to be associated with bad prognosis by itself, as it can be found in cases with good and bad outcomes...
  18. doi request reprint Persistent polyclonal B-cell lymphocytosis with splenomegaly: histologic description of 2 cases
    Azahara Martínez-López
    Department of Pathology, Hospital Universitario Marques de Valdecilla, IFIMAV, Santander, Spain
    Am J Surg Pathol 37:1085-90. 2013
    ..These included a partially preserved architecture with infiltration of the red pulp by small lymphocytes and partial replacement of the white pulp. Suggestions for identifying the disorder are made...
  19. doi request reprint Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers
    Socorro Maria Rodriguez Pinilla
    Lymphoma Group, Molecular Pathology Programme, Monoclonal Antibody Unit, Biotechnology Programme, Spanish National Cancer Research Centre, Hospital Universitario 12 de Octubre, Madrid, Spain
    Am J Surg Pathol 33:81-90. 2009
    ..Moreover, these findings suggest that B-cell stimulation by FTH could also take place in some cutaneous T-cell lymphomas...
  20. doi request reprint TCL1A expression delineates biological and clinical variability in B-cell lymphoma
    Mohit Aggarwal
    Molecular Pathology Programme, Spanish National Cancer Research Centre CNIO, Madrid, Spain
    Mod Pathol 22:206-15. 2009
    ....
  21. pmc Expression pattern of XBP1(S) in human B-cell lymphomas
    Lorena Maestre
    Monoclonal Antibodies Unit, Biotechnology Program, Spanish National Cancer Centre CNIO, Madrid, Spain
    Haematologica 94:419-22. 2009
    ..Furthermore, our results establish a direct and practical means of assessing ER stress in human tumors...
  22. doi request reprint Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway
    María J Bueno
    Cell Division and Cancer Group, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain
    Blood 117:6255-66. 2011
    ..Some of these Myc-targeting miRNAs are repressed by Myc, suggesting that these tumors are a consequence of the unbalanced activity of Myc versus miRNAs...
  23. doi request reprint Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases
    Manuela Mollejo
    Pathology Department, Hospital Virgen de la Salud, Toledo, Spain
    Am J Surg Pathol 33:730-8. 2009
    ..Recognition of the distinct nature of these tumors should facilitate appropriate studies for determining the best therapy for such cases...
  24. pmc Cyclooxygenase-2 expression in bladder cancer and patient prognosis: results from a large clinical cohort and meta-analysis
    Maciej J Czachorowski
    Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre CNIO, Madrid, Spain
    PLoS ONE 7:e45025. 2012
    ..The meta-analysis confirmed these results. We did not find evidence that COX2 expression is an independent prognostic marker of recurrence, progression or survival in patients with UCB...
  25. ncbi request reprint Cherubism associated with neurofibromatosis type 1, and multiple osteolytic lesions of both femurs: a previously undescribed association of findings
    Francisco J Martinez-Tello
    Departamento de Anatomia Patologica, Hospital Universitario 12 de Octubre, Carretera de Andalucía Km 5400, 28041, Madrid, Spain
    Skeletal Radiol 34:793-8. 2005
    ..We have been unable to find a similar case in the world literature. We discuss our findings in relationship with a number of syndromes that present clinical, radiological or pathological similarities...